Fertility Market in the US 2016-2020

Fertility market in the US analysis

Technavio’s market research analyst predicts the fertility market in the US to grow at steadily a CAGR of around 4% by 2020. The fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.

Fertility market growth drivers

Cultural shifts in the US will also have a positive impact on the market growth. Recently, it has been observed that there is an increase in the number of same-sex parents in the US. According to Child Welfare, it was estimated that during 2012, up to 6 million children in the US were parented by same-sex parents. In this market study, analysts have predicted that the number of women in same-sex relationships using donor sperm has risen from 15% (before same-sex marriage) to 20% after regulatory changes for same-sex marriage. This growing social acceptance of same-sex marriages will indirectly aid in the growth of this market during the predicted period.

Fertility market segmentation by treatment type

• ART
• Infertility drugs

At present, the ART segment leads the market and accounts for approximately 67% of the total market share. This segment includes in-vitro fertilization and other treatment options like intrauterine insemination, reproductive surgery, and surrogacy. In-vitro fertilization (IVF) accounts for around 99% of all the ART treatments. Since IVF is one of the most popular assisted fertility techniques, its augmented adoption due to its enhanced rate of success will result in the strong growth of this market segment during the predicted period.